Cargando…

Outcome of the efficacy of Chinese herbal medicine for functional constipation: A systematic review and meta-analysis

BACKGROUND: Functional constipation (FC) is a common and chronic gastrointestinal disease and its treatment remains challenging. AIM: To evaluate the efficacy and safety of Chinese herbal medicine (CHM) on efficacy rate, global symptoms, bowel movements and the Bristol Stool Scale score in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyu, Zipan, Fan, Yibo, Bai, Yang, Liu, Tao, Zhong, Linda LD, Liang, Hui-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198889/
https://www.ncbi.nlm.nih.gov/pubmed/35801027
http://dx.doi.org/10.12998/wjcc.v10.i15.4856
_version_ 1784727742235803648
author Lyu, Zipan
Fan, Yibo
Bai, Yang
Liu, Tao
Zhong, Linda LD
Liang, Hui-Feng
author_facet Lyu, Zipan
Fan, Yibo
Bai, Yang
Liu, Tao
Zhong, Linda LD
Liang, Hui-Feng
author_sort Lyu, Zipan
collection PubMed
description BACKGROUND: Functional constipation (FC) is a common and chronic gastrointestinal disease and its treatment remains challenging. AIM: To evaluate the efficacy and safety of Chinese herbal medicine (CHM) on efficacy rate, global symptoms, bowel movements and the Bristol Stool Scale score in patients with FC by summarizing current available randomized controlled trials (RCTs). METHODS: RCTs with CHM to treat FC were identified by a systematic search of six databases from inception to October 20, 2020. Two independent reviewers assessed the quality of the included articles and extracted data. Meta-analyses were performed to odds ratio (OR), mean differences (MD) and 95% confidence interval (CI) using random-effects models. Subgroup analyses and sensitivity analyses were used to explore and interpret the sources of heterogeneity. The funnel plot, Begg’s test and Egger’s test were used to detect publication bias. RESULTS: Ninety-seven studies involving 8693 patients were included in this work. CHM was significantly associated with a higher efficacy rate (OR: 3.62, 95%CI: 3.19-4.11, P < 0.00001) less severe global symptoms (OR: 4.03, 95%CI: 3.49-4.65, P < 0.00001) compared with control treatment, with the low heterogeneity between studies (I(2) = 0%, P = 0.76). CHM was also associated with more frequent bowel movements (MD 0.83, 95%CI: 0.67-0.98, P < 0.00001), a lower score on the Bristol Stool Scale (OR: 1.63, 95%CI: 1.15-2.32, P < 0.006), and a not significant recurrence rate (OR: 0.47, 95%CI: 0.22-0.99, P = 0.05). No serious adverse effects of CHM were reported. CONCLUSION: In this meta-analysis, we found that CHM may have potential benefits in increasing the number of bowel movements, improving stool characteristics and alleviating global symptoms in FC patients. However, a firm conclusion could not be reached because of the poor quality of the included trials. Further trials with higher quality are required.
format Online
Article
Text
id pubmed-9198889
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-91988892022-07-06 Outcome of the efficacy of Chinese herbal medicine for functional constipation: A systematic review and meta-analysis Lyu, Zipan Fan, Yibo Bai, Yang Liu, Tao Zhong, Linda LD Liang, Hui-Feng World J Clin Cases Meta-Analysis BACKGROUND: Functional constipation (FC) is a common and chronic gastrointestinal disease and its treatment remains challenging. AIM: To evaluate the efficacy and safety of Chinese herbal medicine (CHM) on efficacy rate, global symptoms, bowel movements and the Bristol Stool Scale score in patients with FC by summarizing current available randomized controlled trials (RCTs). METHODS: RCTs with CHM to treat FC were identified by a systematic search of six databases from inception to October 20, 2020. Two independent reviewers assessed the quality of the included articles and extracted data. Meta-analyses were performed to odds ratio (OR), mean differences (MD) and 95% confidence interval (CI) using random-effects models. Subgroup analyses and sensitivity analyses were used to explore and interpret the sources of heterogeneity. The funnel plot, Begg’s test and Egger’s test were used to detect publication bias. RESULTS: Ninety-seven studies involving 8693 patients were included in this work. CHM was significantly associated with a higher efficacy rate (OR: 3.62, 95%CI: 3.19-4.11, P < 0.00001) less severe global symptoms (OR: 4.03, 95%CI: 3.49-4.65, P < 0.00001) compared with control treatment, with the low heterogeneity between studies (I(2) = 0%, P = 0.76). CHM was also associated with more frequent bowel movements (MD 0.83, 95%CI: 0.67-0.98, P < 0.00001), a lower score on the Bristol Stool Scale (OR: 1.63, 95%CI: 1.15-2.32, P < 0.006), and a not significant recurrence rate (OR: 0.47, 95%CI: 0.22-0.99, P = 0.05). No serious adverse effects of CHM were reported. CONCLUSION: In this meta-analysis, we found that CHM may have potential benefits in increasing the number of bowel movements, improving stool characteristics and alleviating global symptoms in FC patients. However, a firm conclusion could not be reached because of the poor quality of the included trials. Further trials with higher quality are required. Baishideng Publishing Group Inc 2022-05-26 2022-05-26 /pmc/articles/PMC9198889/ /pubmed/35801027 http://dx.doi.org/10.12998/wjcc.v10.i15.4856 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Meta-Analysis
Lyu, Zipan
Fan, Yibo
Bai, Yang
Liu, Tao
Zhong, Linda LD
Liang, Hui-Feng
Outcome of the efficacy of Chinese herbal medicine for functional constipation: A systematic review and meta-analysis
title Outcome of the efficacy of Chinese herbal medicine for functional constipation: A systematic review and meta-analysis
title_full Outcome of the efficacy of Chinese herbal medicine for functional constipation: A systematic review and meta-analysis
title_fullStr Outcome of the efficacy of Chinese herbal medicine for functional constipation: A systematic review and meta-analysis
title_full_unstemmed Outcome of the efficacy of Chinese herbal medicine for functional constipation: A systematic review and meta-analysis
title_short Outcome of the efficacy of Chinese herbal medicine for functional constipation: A systematic review and meta-analysis
title_sort outcome of the efficacy of chinese herbal medicine for functional constipation: a systematic review and meta-analysis
topic Meta-Analysis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198889/
https://www.ncbi.nlm.nih.gov/pubmed/35801027
http://dx.doi.org/10.12998/wjcc.v10.i15.4856
work_keys_str_mv AT lyuzipan outcomeoftheefficacyofchineseherbalmedicineforfunctionalconstipationasystematicreviewandmetaanalysis
AT fanyibo outcomeoftheefficacyofchineseherbalmedicineforfunctionalconstipationasystematicreviewandmetaanalysis
AT baiyang outcomeoftheefficacyofchineseherbalmedicineforfunctionalconstipationasystematicreviewandmetaanalysis
AT liutao outcomeoftheefficacyofchineseherbalmedicineforfunctionalconstipationasystematicreviewandmetaanalysis
AT zhonglindald outcomeoftheefficacyofchineseherbalmedicineforfunctionalconstipationasystematicreviewandmetaanalysis
AT lianghuifeng outcomeoftheefficacyofchineseherbalmedicineforfunctionalconstipationasystematicreviewandmetaanalysis